However, ACEI/ARB therapy was considered to have the probability of increasing the risk of SARS-CoV-2 infection 24, but it is needed to clarify whether ACE2 could upregulate viral load and further result in disease severity to identify the multifaceted role of the ACE2 in COVID-19. Here, ACE2 is linked to COVID-19.